Skip to main content
. 2019 Apr 26;2019(4):CD004055. doi: 10.1002/14651858.CD004055.pub2

24.1. Analysis.

24.1

Comparison 24 Topical calcineurin inhibitors: pimecrolimus 1% cream versus vehicle, Outcome 1 Primary: investigatorā€rated good/excellent control of symptoms pimecrolimus cream vs vehicle.